SCHEMBL4355012

SCHEMBL4355012

Nc1ncc2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 9/20 0.63
PIK3CA P42336 3/20 0.59
PIK3CB P42338 3/20 0.59
PIK3CD O00329 2/20 0.59
PIK3C2B O00750 1/20 0.59
PDXK O00764 1/20 0.59
GAK O14976 1/20 0.59
MAP3K7 O43318 1/20 0.59
RIPK2 O43353 1/20 0.59
PIP5K1C O60331 1/20 0.59
STK16 O75716 1/20 0.59
PIK3C2G O75747 1/20 0.59
PRKD3 O94806 1/20 0.59
OXSR1 O95747 1/20 0.59
LATS1 O95835 1/20 0.59
ABL1 P00519 1/20 0.59
EGFR P00533 1/20 0.59
ERBB2 P04626 1/20 0.59
LCK P06239 1/20 0.59
BRAF P15056 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12068878 0.81 PIK3CG (0.55) PIK3CGJAK1TYK2ADORA1ADORA2A
SCHEMBL14983456 0.79 PIK3CG (0.62) PIK3CGCLK1ADORA1ADORA2AADORA2B
SCHEMBL13019165 0.79 PIK3CG (0.63) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Hydrochloric Acid SCHEMBL3741616 0.78 PIK3CG (0.61) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
SCHEMBL27632005 0.76 ADORA1 (0.62) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29506727 0.75 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
SCHEMBL12198179 0.75 PIK3CG (0.78) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL360279 0.75 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29369340 0.75 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29411790 0.75 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039683-B1 Vasculostatic agents and methods of use thereof TARGEGEN INC (US) 2012-12-19 EP disclosed
EP-2039683-A2 Vasculostatic agents and methods of use thereof Targegen, Inc. (US) 2009-03-25 EP disclosed